Valmet's Interim Review January 1 - September 30, 2025
Improving performance and landmark wins in a challenging market.
According to President and CEO Thomas Hinnerskov,
Valmet's orders received grew organically by seven percent to approximately EUR 1.1 billion in Q3, marking our fourth consecutive quarter of organic growth despite a subdued environment in parts of our end markets.
- Orders received grew organically by 7% to EUR 1.1 billion in Q3.
- Process Performance Solutions led the growth with an 11% organic increase.
- A large tissue order was secured in the United States, setting a new benchmark.
- Net sales were stable at EUR 1.3 billion.
- Comparable EBITA and margin were EUR 159 million and 12.3%, respectively.
Author's summary: Valmet reports improved performance in Q3 2025 despite market Challenges.
More News
- DANA ALMASSOVA — Визитка Казахстана
- Matthew Lillard Admits He Doesn’t Have “Huge Part” In ‘FNAF 2’, Teases Potential Trilogy Showdown
- Netflix, Inc. Common Stock NFLX
- Matthew Lillard admits ‘feeling hurt’ by Quentin Tarantino’s disparaging remarks
- Why Netflix Shares Falling Today
- [Trump Berates Reporters, Gets Mystery MRI & Closes ...]
- Netflix NFC.DE Faces a Price Drop Amid Market Volatility
- Miss Universe 2025
- Dana Almassova Kazakhstan
- Netflix, Inc. (NFLX) Stock Price, Quote, News & Analysis